Endoscopic Retrograde Cholangiopancreatography (ERCP) Global Market Report 2025

Description

Endoscopic retrograde cholangiopancreatography (ERCP) is a diagnostic and therapeutic medical procedure that integrates endoscopy with X-ray imaging to address conditions affecting the bile ducts, gallbladder, and pancreas. The process involves inserting a flexible, illuminated tube (endoscope) through the mouth into the small intestine, enabling physicians to diagnose and treat issues such as blockages or stones.

The primary products used in ERCP include endoscopes, endotherapy devices, visualization systems, and energy devices. Endoscopes are flexible tubes with a light and camera, allowing healthcare professionals to visualize the internal organs, particularly the digestive tract, during procedures such as ERCP. The procedure addresses various disease indications, including gastroesophageal reflux disease (GERD), gastrointestinal cancer, Barrett's esophagus, bile duct diseases, peptic ulcer disease, Crohn's disease, intestinal pseudo-obstruction, Ogilvie syndrome, and others. ERCP applications include biliary sphincterotomy, biliary dilatation, biliary stenting, pancreatic sphincterotomy, pancreatic duct dilatation, and pancreatic duct stenting. The key end users are hospitals and clinics, ambulatory surgery centers, and other healthcare facilities.

The endoscopic retrograde cholangiopancreatography (ERCP) market research report is one of a series of new reports from The Business Research Company that provides endoscopic retrograde cholangiopancreatography (ERCP) market statistics, including endoscopic retrograde cholangiopancreatography (ERCP) industry global market size, regional shares, competitors with endoscopic retrograde cholangiopancreatography (ERCP) market share, detailed endoscopic retrograde cholangiopancreatography (ERCP) market segments, market trends and opportunities, and any further data you may need to thrive in the endoscopic retrograde cholangiopancreatography (ERCP) industry. This endoscopic retrograde cholangiopancreatography (ERCP) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The endoscopic retrograde cholangiopancreatography (ERCP) market size has grown strongly in recent years. It will grow from $1.72 billion in 2024 to $1.87 billion in 2025 at a compound annual growth rate (CAGR) of 8.87%. The growth during the historical period can be attributed to the increasing prevalence of chronic gastrointestinal diseases, expanded applications of ERCP, a rising incidence of pancreatic cancer, growing government investments, and an increase in medical tourism.

The endoscopic retrograde cholangiopancreatography (ERCP) market size is expected to see strong growth in the next few years. It will grow to $2.60 billion in 2029 at a compound annual growth rate (CAGR) of 8.58%. The growth forecast for this period is driven by the rising prevalence of gastrointestinal conditions, an increasing incidence of cancer, heightened investment focus, a growing occurrence of pancreatic duct conditions, and rising demand for endoscopes. Key trends expected include technological advancements, partnerships for research and development, the expansion of healthcare infrastructure, increased government healthcare initiatives, and the development of advanced ERCP products.

The rising prevalence of gastrointestinal conditions is anticipated to drive the growth of the endoscopic retrograde cholangiopancreatography (ERCP) market. These conditions encompass a wide range of disorders affecting the gastrointestinal (GI) tract, including the mouth, esophagus, stomach, intestines, rectum, anus, and accessory organs such as the liver, gallbladder, and pancreas. Factors such as dietary changes, an aging population, antibiotic use, lifestyle habits, and environmental influences contribute to the increasing incidence of these conditions. ERCP provides a minimally invasive solution for diagnosing and treating bile and pancreatic duct issues, including gallstones, strictures, tumors, and infections. For example, the American Cancer Society estimated in January 2024 that approximately 26,890 new cases of stomach cancer would occur in the United States, with around 10,880 deaths expected. As gastrointestinal conditions become more common, the demand for ERCP procedures continues to grow.

Companies in the ERCP market are advancing procedures by developing innovative technologies, such as cholangioscope systems, for enhanced diagnosis and treatment. These systems provide high-resolution imaging of the bile and pancreatic ducts, improving therapeutic outcomes. In July 2024, Penlon Limited introduced the VedVision Cholangioscope Direct Visualization System, a cutting-edge device offering precise imaging for ERCP procedures. Its features include a 2 mm accessory channel and a dedicated guidewire channel, along with accessories such as biopsy forceps, stone extraction baskets, cytology brushes, and polypectomy snares, enhancing diagnostic and therapeutic capabilities.

In October 2022, OmniVision Technologies Inc., a semiconductor manufacturer based in the United States, collaborated with AdaptivEndo LLC to develop a unified platform for hybrid and single-use endoscopes. This platform is designed for use across various medical specialties, including gastroenterology, hepatology, urology, and gynecology, enabling a more streamlined approach to procedures such as endoscopic retrograde cholangiopancreatography (ERCP) and other endoscopic techniques. AdaptivEndo LLC, also based in the United States, specializes in single-use endoscopy devices that combine the functionalities of endoscopic ultrasound (EUS) and ERCP, offering enhanced versatility and efficiency in clinical practice.

Major players in the endoscopic retrograde cholangiopancreatography (ERCP) market are Medtronic plc, Fujifilm Holdings Corporation, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Ottomed Endoscopy, W. L. Gore & Associates Inc., Streis plc, Cook Group, KARL STORZ SE & Co. KG, CONMED Corporation, PENTAX Medical Inc., AMBU Inc., Samsung Medison Co. Ltd., Medi-Globe GmbH, Telemed System Inc., Micro-Tech Endoscopy Inc., Hobbs Medical Inc., Shaili Endoscopy Pvt. Ltd.

North America was the largest region in the endoscopic retrograde cholangiopancreatography (ERCP) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in endoscopic retrograde cholangiopancreatography (ERCP) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the endoscopic retrograde cholangiopancreatography (ERCP) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The endoscopic retrograde cholangiopancreatography (ERCP) market consists of revenues earned by entities by providing services such as diagnostic services, therapeutic services, post-operative, and follow-up care. The market value includes the value of related goods sold by the service provider or included within the service offering. The endoscopic retrograde cholangiopancreatography (ERCP) market also includes sales of biliary stents, guidewires, and catheters. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Endoscopic Retrograde Cholangiopancreatography (ERCP) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on endoscopic retrograde cholangiopancreatography (ercp) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for endoscopic retrograde cholangiopancreatography (ercp) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The endoscopic retrograde cholangiopancreatography (ercp) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product: Endoscopes; Endotherapy Devices; Visualization Systems; Energy Devices
2) By Disease Indication: Gastroesophageal Reflux Disease (GERD); Gastrointestinal Cancer; Barrett's Esophagus; Bile Duct Diseases; Peptic Ulcer Disease; Crohn's Disease; Intestinal Pseudo-Obstruction; Ogilvie Syndrome; Other Indications
3) By Application: Biliary Sphincterotomy; Biliary Dilatation; Biliary Stenting; Pancreatic Sphincterotomy; Pancreatic Duct Dilatation; Pancreatic Duct Stentin
4) By End User: Hospitals And Clinics; Ambulatory Surgery Centers; Other End Users
Subsegments:
1) By Endoscopes: Flexible Endoscopes; Semi-Rigid Endoscopes; High-Resolution Endoscopes
2) By Endotherapy Devices: Stone Extraction Devices; Balloon Dilatation Catheters; Stents; Biopsy Forceps
3) By Visualization Systems: High-Definition Visualization Systems; Endoscopic Imaging Systems; Video Endoscopes
4) By Energy Devices: Electrosurgical Devices; Laser Devices; Argon Plasma Coagulation Systems
Companies Mentioned: Medtronic plc; Fujifilm Holdings Corporation; Siemens Healthineers AG; Stryker Corporation; Boston Scientific Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r33700

1. Executive Summary

2. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Characteristics

3. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Trends And Strategies

4. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Growth Analysis And Strategic Analysis Framework

5.1. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Growth Rate Analysis
5.4. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Total Addressable Market (TAM)

6. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Segmentation

6.1. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Endoscopes
Endotherapy Devices
Visualization Systems
Energy Devices
6.2. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gastroesophageal Reflux Disease (GERD)
Gastrointestinal Cancer
Barrett's Esophagus
Bile Duct Diseases
Peptic Ulcer Disease
Crohn's Disease
Intestinal Pseudo-Obstruction
Ogilvie Syndrome
Other Indications
6.3. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Biliary Sphincterotomy
Biliary Dilatation
Biliary Stenting
Pancreatic Sphincterotomy
Pancreatic Duct Dilatation
Pancreatic Duct Stenting
Other Applications
6.4. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Ambulatory Surgery Centers
Other End Users
6.5. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Sub-Segmentation Of Endoscopes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Flexible Endoscopes
Semi-Rigid Endoscopes
High-Resolution Endoscopes
6.6. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Sub-Segmentation Of Endotherapy Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Stone Extraction Devices
Balloon Dilatation Catheters
Stents
Biopsy Forceps
6.7. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Sub-Segmentation Of Visualization Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
High-Definition Visualization Systems
Endoscopic Imaging Systems
Video Endoscopes
6.8. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Sub-Segmentation Of Energy Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Electrosurgical Devices
Laser Devices
Argon Plasma Coagulation Systems

7. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Regional And Country Analysis

7.1. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

8.1. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

9.1. China Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
9.2. China Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

10.1. India Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

11.1. Japan Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
11.2. Japan Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

12.1. Australia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

13.1. Indonesia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

14.1. South Korea Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
14.2. South Korea Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

15.1. Western Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
15.2. Western Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

16.1. UK Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

17.1. Germany Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

18.1. France Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

19.1. Italy Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

20.1. Spain Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

21.1. Eastern Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
21.2. Eastern Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

22.1. Russia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

23.1. North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
23.2. North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

24.1. USA Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
24.2. USA Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

25.1. Canada Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
25.2. Canada Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

26.1. South America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
26.2. South America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

27.1. Brazil Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

28.1. Middle East Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
28.2. Middle East Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

29.1. Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
29.2. Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Competitive Landscape And Company Profiles

30.1. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Competitive Landscape
30.2. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Company Profiles
- 30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Fujifilm Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Other Major And Innovative Companies

31.1. B. Braun Melsungen AG
31.2. Olympus Corporation
31.3. Ottomed Endoscopy
31.4. W. L. Gore & Associates Inc.
31.5. Streis plc
31.6. Cook Group
31.7. KARL STORZ SE & Co. KG
31.8. CONMED Corporation
31.9. PENTAX Medical Inc.
31.10. AMBU Inc.
31.11. Samsung Medison Co. Ltd.
31.12. Medi-Globe GmbH
31.13. Telemed System Inc.
31.14. Micro-Tech Endoscopy Inc.
31.15. Hobbs Medical Inc.

32. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

34. Recent Developments In The Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

35. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market High Potential Countries, Segments and Strategies

35.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Market In 2029 - Countries Offering Most New Opportunities
35.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Market In 2029 - Segments Offering Most New Opportunities
35.3 Endoscopic Retrograde Cholangiopancreatography (ERCP) Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer